Alerts will be sent to your verified email
Verify Email
BIOFILCHEM
|
Biofil Chem & Pharma
|
Makers Laboratories
|
Vivimed Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.39 % | 0.31 % | 10.89 % |
|
5yr average Equity Multiplier
|
2.06 | 2.36 | -33.72 |
|
5yr Average Asset Turnover Ratio
|
0.95 | 0.7 | 0.27 |
|
5yr Avg Net Profit Margin
|
2.38 % | -0.21 % | -54.08 % |
|
Price to Book
|
3.19 | 0.98 | 0.0 |
|
P/E
|
23.65 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
75.63 Days | 75.08 Days | 184.52 Days |
|
Inventory Days
|
28.27 Days | 107.1 Days | 244.76 Days |
|
Days Receivable
|
389.8 Days | 71.83 Days | 246.32 Days |
|
Days Payable
|
203.89 Days | 106.28 Days | 159.64 Days |
|
5yr Average Interest Coverage Ratio
|
23.53 | 4.73 | -6.61 |
|
5yr Avg ROCE
|
6.37 % | 6.35 % | -13.87 % |
|
5yr Avg Operating Profit Margin
|
3.78 % | 7.59 % | -26.56 % |
|
5 yr average Debt to Equity
|
0.03 | 0.21 | -13.68 |
|
5yr CAGR Net Profit
|
-14.7 % | n/a | -14.97 % |
|
5yr Average Return on Assets
|
2.37 % | 0.25 % | -10.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
46.79 % | 61.27 % | 7.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 14.8 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.03 % | 0.0 | -13.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biofil Chem & Pharma
|
Makers Laboratories
|
Vivimed Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|